LEVOPHED Drug Patent Profile
✉ Email this page to a colleague
When do Levophed patents expire, and when can generic versions of Levophed launch?
Levophed is a drug marketed by Hospira and is included in one NDA.
The generic ingredient in LEVOPHED is norepinephrine bitartrate. There are five drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the norepinephrine bitartrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Levophed
A generic version of LEVOPHED was approved as norepinephrine bitartrate by MEITHEAL on March 3rd, 2003.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LEVOPHED?
- What are the global sales for LEVOPHED?
- What is Average Wholesale Price for LEVOPHED?
Summary for LEVOPHED
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 77 |
| Clinical Trials: | 12 |
| Drug Prices: | Drug price information for LEVOPHED |
| What excipients (inactive ingredients) are in LEVOPHED? | LEVOPHED excipients list |
| DailyMed Link: | LEVOPHED at DailyMed |
Recent Clinical Trials for LEVOPHED
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Wright State University | Phase 3 |
| Kasr El Aini Hospital | Phase 4 |
| Yale University | Early Phase 1 |
Pharmacology for LEVOPHED
| Drug Class | Catecholamine |
US Patents and Regulatory Information for LEVOPHED
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospira | LEVOPHED | norepinephrine bitartrate | INJECTABLE;INJECTION | 007513-001 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
